Vancomycin associated acute kidney injury in pediatric patients.
INTRODUCTION:Vancomycin associated acute kidney injury (vAKI) is a well known complication in pediatric patients. Identification and characterization of the incidence and risk factors for vAKI in the pediatric population would assist clinicians in potentially preventing or mitigating vAKI. METHODS A...
Main Authors: | Brady S Moffett, Jennifer Morris, Charissa Kam, Marianne Galati, Ankhi Dutta, Ayse Akcan-Arikan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6169857?pdf=render |
Similar Items
-
Acute Kidney Injury in Pediatric Treated with Vancomycin and Piperacillin-Tazobactam in Tertiary Care Hospital
by: Mohammed Al Nuhait, et al.
Published: (2018-01-01) -
Vancomycin-associated acute kidney injury in Hong Kong in 2012–2016
by: Xuzhen Qin, et al.
Published: (2020-02-01) -
Vancomycin Associated Acute Kidney Injury: A Longitudinal Study in China
by: Pan Kunming, et al.
Published: (2021-03-01) -
Vancomycin induced acute kidney injury: a review of the literature
by: Kerry Anne Rambaran, et al.
Published: (2016-07-01) -
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury
by: Linda Awdishu, et al.
Published: (2021-03-01)